Retrospective analysis of large‑scale research screening of construction workers for the early diagnosis of mesothelioma

Hirohashi,Tomoko; Igarashi,Kiyoko; Abe,Masaaki; Maeda,Masahiro; Hino,Okio

doi:10.3892/mco.2013.197

January-February 2014 Volume 2 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

January-February 2014 Volume 2 Issue 1

Full Size Image

Article

Retrospective analysis of large‑scale research screening of construction workers for the early diagnosis of mesothelioma

Authors:
- Tomoko Hirohashi
- Kiyoko Igarashi
- Masaaki Abe
- Masahiro Maeda
- Okio Hino
View Affiliations / Copyright

Affiliations: Department of Pathology and Oncology, School of Medicine, Juntendo University, Bunkyo-Ku, Tokyo 113‑8421, Japan, Byotai‑seiri Laboratory, Itabashi-Ku, Tokyo 173‑0025, Japan, Immuno‑Biological Laboratories, Co., Ltd., Fujioka-shi, Gunma 375‑0005, Japan
Pages: 26-30
|
Published online on: October 2, 2013

https://doi.org/10.3892/mco.2013.197
Expand metrics +

Abstract

The early diagnosis of mesothelioma, an aggressive malignant tumor, is considered to be important for prognosis. X‑ray is commonly used for the assessment of a mass in a population exhibiting a risk factor. However, there are currently no available studies indicating that such an assessment may be used to achieve early diagnosis and improve the patient's outcome. We previously reported that N‑ERC/mesothelin may be a useful blood tumor marker for mesothelioma. In order to investigate whether this tumor marker is useful for early diagnosis in a mass examination, in 2007 we initiated a 5‑year large‑scale screening of construction workers with a risk of asbestos exposure in Japan. Blood samples were collected annually and N‑ERC/mesothelin levels were determined. Based on the results of those findings, along with medical history and related data, we screened the participants to identify a high‑risk population. As a result, 62 subjects were identified among ~40,000 participants as the high‑risk population. Two of these 62 participants subsequently developed mesothelioma, although the remaining participants have not yet developed mesothelioma. In conclusion, N‑ERC/mesothelin may be useful as a blood tumor marker in the early diagnosis of mesothelioma in a mass examination. A future prospective study to confirm the findings of this research screening is currently under planning.

View Figures

View References

1.	Gemba K, Fujimoto N, Kato K, Aoe K, Takeshima Y, Inai K and Kishimoto T: National survey of mesothelioma and asbestos exposure in Japan. Cancer Sci. 103:483–490. 2012. View Article : Google Scholar : PubMed/NCBI
2.	Nakano T: Current therapies for malignant pleural mesothelioma. Environ Health Prev Med. 13:75–83. 2008. View Article : Google Scholar : PubMed/NCBI
3.	Robinson BW, Musk AW and Lake RA: Mesothelioma. Lancet. 366:397–408. 2005. View Article : Google Scholar : PubMed/NCBI
4.	Reid A, de Klerk N, Ambrosini G, Olsen N, Pang SC and Musk AW: The additional risk of mesothelioma in former workers and residents of Wittenoom with benign pleural disease or asbestosis. Occup Environ Med. 62:665–669. 2005. View Article : Google Scholar : PubMed/NCBI
5.	Sandén A and Järvholm B: A study of possible predictors of mesothelioma in shipyard workers exposed to asbestos. J Occup Med. 33:770–773. 1991.PubMed/NCBI
6.	Hino O, Kobayashi E, Nishizawa M, et al: Renal carcinogenesis in the Eker rat. J Cancer Res Clin Oncol. 121:602–605. 1995. View Article : Google Scholar : PubMed/NCBI
7.	Yamashita Y, Yokoyama M, Kobayashi E, Takai S and Hino O: Mapping and determination of the cDNA sequence of the Erc gene preferentially expressed in renal cell carcinoma in the Tsc2 gene mutant (Eker) rat model. Biochem Biophys Res Commun. 275:134–140. 2000. View Article : Google Scholar : PubMed/NCBI
8.	Hino O: Multistep renal carcinogenesis in the Eker (Tsc 2 gene mutant) rat model. Curr Mol Med. 4:807–811. 2004. View Article : Google Scholar : PubMed/NCBI
9.	Hassan R, Bera T and Pastan I: Mesothelin: a new target for immunotherapy. Clin Cancer Res. 10:3937–3942. 2004. View Article : Google Scholar : PubMed/NCBI
10.	Shiomi K, Miyamoto H, Segawa T, et al: Novel ELISA system for detection of N-ERC/mesothelin in the sera of mesothelioma patients. Cancer Sci. 97:928–932. 2006. View Article : Google Scholar : PubMed/NCBI
11.	Shiomi K, Hagiwara Y, Sonoue K, et al: Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma. Clin Cancer Res. 14:1431–1437. 2008. View Article : Google Scholar
12.	Imashimizu K, Shiomi K, Maeda M, Aoki N, Igarashi K, Suzuki F, Koizumi M, Suzuki K and Hino O: Feasibility of large-scale screening using N-ERC/mesothelin levels in the blood for the early diagnosis of mesothelioma. Exp Ther Med. 2:409–411. 2011.PubMed/NCBI
13.	Shiomi K, Shiomi S, Ishinaga Y, et al: Impact of renal failure on the tumor markers of mesothelioma, N-ERC/mesothelin and osteopontin. Anticancer Res. 31:1427–1430. 2011.PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Retrospective analysis of large‑scale research screening of construction workers for the early diagnosis of mesothelioma

This article is mentioned in:

Abstract

Figure 1

Related Articles